Interestingly, studies have shown that the non‐SUMOylated mutant of BACE1 is susceptible to lysosomal degradation, leading to a decrease in Aβ formation and a reduction in cognitive dysfunction in mouse models of AD.80 Here, BACE1 is linked to Alzheimer disease.